Inventor · Dover, MA, US

Denisa D. Wagner

13Patents
2h-index
27Co-inventors
54Inventor score

Filing activity: Jan 26, 1995 → Oct 2, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US9642822B2 Methods for treating and preventing neutrophil-derived net toxicity and thrombosis Chemistry; Metallurgy 15 Active
US7387777B2 Methods of treating hemophilia or von willebrand disease with p-selectin Physics 9 Expired
US5807745A Method of inhibiting PADGEM-mediated or ELAM-1-mediated leukocyte adhesion using an inhibitor comprising a Le.sup.x core component Chemistry; Metallurgy 2 Expired
US6861504B2 Compounds and methods for the modulation of CD154 Human Necessities 1 Expired
US11124787B2 ADAMTS13-containing compositions having thrombolytic activity Human Necessities 0 Active
US11426405B2 Inhibition of JAK-STAT signaling inhibits formation of neutrophil extracellular traps (NETs) Chemistry; Metallurgy 0 Active
US7271152B2 Compounds and methods for the modulation of CD154 Human Necessities 0 Expired
US10639307B2 Methods relating to the diagnosis and treatment of preeclampsia comprising administration of ADAMTS13 polypeptides Human Necessities 0 Active
US11400139B2 Anti-NET compounds for treating and preventing fibrosis and for facilitating wound healing Chemistry; Metallurgy 0 Active
US11819540B2 Methods for treating and preventing neutrophil-derived net toxicity and thrombosis Human Necessities 0 Active
US11510970B2 Methods for treating and preventing neutrophil-derived net toxicity and thrombosis Chemistry; Metallurgy 0 Active
US10617742B2 Methods for treating and preventing neutrophil-derived net toxicity and thrombosis Chemistry; Metallurgy 0 Active
US10233436B2 ADAMTS13-containing compositions having thrombolytic activity Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.